Latest Articles

Publication Date
Cancelling cervical cancer - The New Indian Express

Cancelling cervical cancer The New Indian Express

Published: Jan. 29, 2025, 6:08 a.m.
Four early warning signs of cervical cancer that women often mistake for something else - Tyla

Four early warning signs of cervical cancer that women often mistake for something else Tyla

Published: Jan. 28, 2025, 12:44 p.m.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …

Published: Dec. 28, 2024, 12:47 p.m.
Transforming cervical cancer protection with the BD Onclarity HPV Assay - Contemporary Obgyn

Transforming cervical cancer protection with the BD Onclarity HPV Assay Contemporary Obgyn

Published: Nov. 25, 2024, 6:54 p.m.
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive

Published: Oct. 24, 2024, 3:55 p.m.
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More - OncLive

Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More OncLive

Published: Oct. 21, 2024, 5:04 p.m.
World Cancer Day 2024: 5 common cancers in women beyond cervical cancer - Hindustan Times

World Cancer Day 2024: 5 common cancers in women beyond cervical cancer Hindustan Times

Published: Feb. 4, 2024, 8 a.m.
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer - Targeted Oncology

KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer Targeted Oncology

Published: Jan. 5, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!